
<!DOCTYPE html>

<html>
  <head>
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <meta name="viewport" content="width=device-width,initial-scale=1">
  <meta http-equiv="x-ua-compatible" content="ie=edge">
  <meta name="lang:clipboard.copy" content="Copy to clipboard">
  <meta name="lang:clipboard.copied" content="Copied to clipboard">
  <meta name="lang:search.language" content="en">
  <meta name="lang:search.pipeline.stopwords" content="True">
  <meta name="lang:search.pipeline.trimmer" content="True">
  <meta name="lang:search.result.none" content="No matching documents">
  <meta name="lang:search.result.one" content="1 matching document">
  <meta name="lang:search.result.other" content="# matching documents">
  <meta name="lang:search.tokenizer" content="[\s\-]+">

  
    <link href="https://fonts.gstatic.com/" rel="preconnect" crossorigin>
    <link href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,500,700|Roboto:300,400,400i,700&display=fallback" rel="stylesheet">

    <style>
      body,
      input {
        font-family: "Roboto", "Helvetica Neue", Helvetica, Arial, sans-serif
      }

      code,
      kbd,
      pre {
        font-family: "Roboto Mono", "Courier New", Courier, monospace
      }
    </style>
  

  <link rel="stylesheet" href="../_static/stylesheets/application.css"/>
  <link rel="stylesheet" href="../_static/stylesheets/application-palette.css"/>
  <link rel="stylesheet" href="../_static/stylesheets/application-fixes.css"/>
  
  <link rel="stylesheet" href="../_static/fonts/material-icons.css"/>
  
  <meta name="theme-color" content="#3f51b5">
  <script src="../_static/javascripts/modernizr.js"></script>
  
<script async src="https://www.googletagmanager.com/gtag/js?id=G-Z6K7QSCHCE"></script>
<script>
    window.dataLayer = window.dataLayer || [];

    function gtag() {
        dataLayer.push(arguments);
    }

    gtag('js', new Date());

    gtag('config', 'G-Z6K7QSCHCE');
</script>
  
  
    <title>Projects &#8212; BioSFGroup homepage</title>
    <link rel="stylesheet" type="text/css" href="../_static/pygments.css" />
    <link rel="stylesheet" type="text/css" href="../_static/material.css" />
    <script data-url_root="../" id="documentation_options" src="../_static/documentation_options.js"></script>
    <script src="../_static/jquery.js"></script>
    <script src="../_static/underscore.js"></script>
    <script src="../_static/doctools.js"></script>
    <link rel="shortcut icon" href="../_static/favicon.png"/>
    <link rel="index" title="Index" href="../genindex/" />
    <link rel="search" title="Search" href="../search/" />
    <link rel="next" title="Software" href="../software/" />
    <link rel="prev" title="Research" href="../research/" />
  
   

  </head>
  <body dir=ltr
        data-md-color-primary=teal data-md-color-accent=green>
  
  <svg class="md-svg">
    <defs data-children-count="0">
      
      <svg xmlns="http://www.w3.org/2000/svg" width="416" height="448" viewBox="0 0 416 448" id="__github"><path fill="currentColor" d="M160 304q0 10-3.125 20.5t-10.75 19T128 352t-18.125-8.5-10.75-19T96 304t3.125-20.5 10.75-19T128 256t18.125 8.5 10.75 19T160 304zm160 0q0 10-3.125 20.5t-10.75 19T288 352t-18.125-8.5-10.75-19T256 304t3.125-20.5 10.75-19T288 256t18.125 8.5 10.75 19T320 304zm40 0q0-30-17.25-51T296 232q-10.25 0-48.75 5.25Q229.5 240 208 240t-39.25-2.75Q130.75 232 120 232q-29.5 0-46.75 21T56 304q0 22 8 38.375t20.25 25.75 30.5 15 35 7.375 37.25 1.75h42q20.5 0 37.25-1.75t35-7.375 30.5-15 20.25-25.75T360 304zm56-44q0 51.75-15.25 82.75-9.5 19.25-26.375 33.25t-35.25 21.5-42.5 11.875-42.875 5.5T212 416q-19.5 0-35.5-.75t-36.875-3.125-38.125-7.5-34.25-12.875T37 371.5t-21.5-28.75Q0 312 0 260q0-59.25 34-99-6.75-20.5-6.75-42.5 0-29 12.75-54.5 27 0 47.5 9.875t47.25 30.875Q171.5 96 212 96q37 0 70 8 26.25-20.5 46.75-30.25T376 64q12.75 25.5 12.75 54.5 0 21.75-6.75 42 34 40 34 99.5z"/></svg>
      
    </defs>
  </svg>
  
  <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer">
  <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search">
  <label class="md-overlay" data-md-component="overlay" for="__drawer"></label>
  <a href="#projects" tabindex="1" class="md-skip"> Skip to content </a>
  <header class="md-header" data-md-component="header">
  <nav class="md-header-nav md-grid">
    <div class="md-flex navheader">
      <div class="md-flex__cell md-flex__cell--shrink">
        <a href="../" title="BioSFGroup homepage"
           class="md-header-nav__button md-logo">
          
              <img src="../_static/logo.svg" height="26"
                   alt="BioSFGroup homepage logo">
          
        </a>
      </div>
      <div class="md-flex__cell md-flex__cell--shrink">
        <label class="md-icon md-icon--menu md-header-nav__button" for="__drawer"></label>
      </div>
      <div class="md-flex__cell md-flex__cell--stretch">
        <div class="md-flex__ellipsis md-header-nav__title" data-md-component="title">
          <span class="md-header-nav__topic">BioSFGroup</span>
          <span class="md-header-nav__topic"> Projects </span>
        </div>
      </div>
      <div class="md-flex__cell md-flex__cell--shrink">
        <label class="md-icon md-icon--search md-header-nav__button" for="__search"></label>
        
<div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" action="../search/" method="get" name="search">
      <input type="text" class="md-search__input" name="q" placeholder="Search"
             autocapitalize="off" autocomplete="off" spellcheck="false"
             data-md-component="query" data-md-state="active">
      <label class="md-icon md-search__icon" for="__search"></label>
      <button type="reset" class="md-icon md-search__icon" data-md-component="reset" tabindex="-1">
        &#xE5CD;
      </button>
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" data-md-scrollfix>
        <div class="md-search-result" data-md-component="result">
          <div class="md-search-result__meta">
            Type to start searching
          </div>
          <ol class="md-search-result__list"></ol>
        </div>
      </div>
    </div>
  </div>
</div>

      </div>
      
        <div class="md-flex__cell md-flex__cell--shrink">
          <div class="md-header-nav__source">
            <a href="https://github.com/svedruziclab/svedruziclab.github.io/" title="Go to repository" class="md-source" data-md-source="github">

    <div class="md-source__icon">
      <svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" viewBox="0 0 24 24" width="28" height="28">
        <use xlink:href="#__github" width="24" height="24"></use>
      </svg>
    </div>
  
  <div class="md-source__repository">
    BioSFGroup website 
  </div>
</a>
          </div>
        </div>
      
      
  
  <script src="../_static/javascripts/version_dropdown.js"></script>
  <script>
    var json_loc = "../"versions.json"",
        target_loc = "../../",
        text = "Versions";
    $( document ).ready( add_version_dropdown(json_loc, target_loc, text));
  </script>
  

    </div>
  </nav>
</header>

  
  <div class="md-container">
    
    
    
  <nav class="md-tabs" data-md-component="tabs">
    <div class="md-tabs__inner md-grid">
      <ul class="md-tabs__list">
          <li class="md-tabs__item"><a href="../" class="md-tabs__link">BioSFGroup homepage</a></li>
      </ul>
    </div>
  </nav>
    <main class="md-main">
      <div class="md-main__inner md-grid" data-md-component="container">
        
          <div class="md-sidebar md-sidebar--primary" data-md-component="navigation">
            <div class="md-sidebar__scrollwrap">
              <div class="md-sidebar__inner">
                <nav class="md-nav md-nav--primary" data-md-level="0">
  <label class="md-nav__title md-nav__title--site" for="__drawer">
    <a href="../" title="BioSFGroup homepage" class="md-nav__button md-logo">
      
        <img src="../_static/logo.svg" alt=" logo" width="48" height="48">
      
    </a>
    <a href="../"
       title="BioSFGroup homepage">BioSFGroup</a>
  </label>
    <div class="md-nav__source">
      <a href="https://github.com/svedruziclab/svedruziclab.github.io/" title="Go to repository" class="md-source" data-md-source="github">

    <div class="md-source__icon">
      <svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" viewBox="0 0 24 24" width="28" height="28">
        <use xlink:href="#__github" width="24" height="24"></use>
      </svg>
    </div>
  
  <div class="md-source__repository">
    BioSFGroup website 
  </div>
</a>
    </div>
  
  

</nav>
              </div>
            </div>
          </div>
          <div class="md-sidebar md-sidebar--secondary" data-md-component="toc">
            <div class="md-sidebar__scrollwrap">
              <div class="md-sidebar__inner">
                
<nav class="md-nav md-nav--secondary">
    <label class="md-nav__title" for="__toc">Contents</label>
  <ul class="md-nav__list" data-md-scrollfix="">
        <li class="md-nav__item"><a href="#projects--page-root" class="md-nav__link">Projects</a><nav class="md-nav">
              <ul class="md-nav__list">
        <li class="md-nav__item"><a href="#the-development-of-novel-bivalent-mechanism-based-inhibitors-of-membrane-embedded-protease-secretase" class="md-nav__link">The development of novel bivalent mechanism-based inhibitors of membrane-embedded protease Î³-secretase</a><nav class="md-nav">
              <ul class="md-nav__list">
        <li class="md-nav__item"><a href="#state-of-the-art" class="md-nav__link">State of the art</a>
        </li>
        <li class="md-nav__item"><a href="#our-work" class="md-nav__link">Our work</a>
        </li></ul>
            </nav>
        </li>
        <li class="md-nav__item"><a href="#the-development-of-mechanism-based-inhibitors-of-human-dna-methyltransferase-dnmt1" class="md-nav__link">The development of mechanism-based inhibitors of human DNA methyltransferase Dnmt1</a><nav class="md-nav">
              <ul class="md-nav__list">
        <li class="md-nav__item"><a href="#id1" class="md-nav__link">State of the art</a>
        </li>
        <li class="md-nav__item"><a href="#id2" class="md-nav__link">Our work</a>
        </li></ul>
            </nav>
        </li>
        <li class="md-nav__item"><a href="#supramolecular-organization-of-nad-h-binding-enzymes" class="md-nav__link">Supramolecular organization of NAD(H)-binding enzymes</a><nav class="md-nav">
              <ul class="md-nav__list">
        <li class="md-nav__item"><a href="#id3" class="md-nav__link">Our work</a>
        </li></ul>
            </nav>
        </li>
        <li class="md-nav__item"><a href="#molecular-docking-techniques-using-deep-learning" class="md-nav__link">Molecular docking techniques using deep learning</a><nav class="md-nav">
              <ul class="md-nav__list">
        <li class="md-nav__item"><a href="#id4" class="md-nav__link">Our work</a>
        </li></ul>
            </nav>
        </li></ul>
            </nav>
        </li>
    
<li class="md-nav__item"><a class="md-nav__extra_link" href="../_sources/projects.rst.txt">Show Source</a> </li>

<li id="searchbox" class="md-nav__item"></li>

  </ul>
</nav>
              </div>
            </div>
          </div>
        
        <div class="md-content">
          <article class="md-content__inner md-typeset" role="main">
            
  
<span id="group-projects"></span><h1 id="projects--page-root">Projects<a class="headerlink" href="#projects--page-root" title="Permalink to this headline">Â¶</a></h1>
<div class="contents local topic" id="list-of-projects">
<p class="topic-title">List of projects</p>
<ul class="simple">
<li><p><a class="reference internal" href="#the-development-of-novel-bivalent-mechanism-based-inhibitors-of-membrane-embedded-protease-secretase" id="id6">The development of novel bivalent mechanism-based inhibitors of membrane-embedded protease Î³-secretase</a></p>
<ul>
<li><p><a class="reference internal" href="#state-of-the-art" id="id7">State of the art</a></p></li>
<li><p><a class="reference internal" href="#our-work" id="id8">Our work</a></p></li>
</ul>
</li>
<li><p><a class="reference internal" href="#the-development-of-mechanism-based-inhibitors-of-human-dna-methyltransferase-dnmt1" id="id9">The development of mechanism-based inhibitors of human DNA methyltransferase Dnmt1</a></p>
<ul>
<li><p><a class="reference internal" href="#id1" id="id10">State of the art</a></p></li>
<li><p><a class="reference internal" href="#id2" id="id11">Our work</a></p></li>
</ul>
</li>
<li><p><a class="reference internal" href="#supramolecular-organization-of-nad-h-binding-enzymes" id="id12">Supramolecular organization of NAD(H)-binding enzymes</a></p>
<ul>
<li><p><a class="reference internal" href="#id3" id="id13">Our work</a></p></li>
</ul>
</li>
<li><p><a class="reference internal" href="#molecular-docking-techniques-using-deep-learning" id="id14">Molecular docking techniques using deep learning</a></p>
<ul>
<li><p><a class="reference internal" href="#id4" id="id15">Our work</a></p></li>
</ul>
</li>
</ul>
</div>

<h2 id="the-development-of-novel-bivalent-mechanism-based-inhibitors-of-membrane-embedded-protease-secretase"><a class="toc-backref" href="#id6">The development of novel bivalent mechanism-based inhibitors of membrane-embedded protease Î³-secretase</a><a class="headerlink" href="#the-development-of-novel-bivalent-mechanism-based-inhibitors-of-membrane-embedded-protease-secretase" title="Permalink to this headline">Â¶</a></h2>
<p>Alzheimerâs disease has been called the most expensive plague of the 21 century. Alzheimerâs disease is slowly progressing, fatal neurodegenerative disorder. Recently Alzheimerâs disease has surpassed malignant diseases as the biggest financial burden for the health care providers in developed countries. This problem is likely to increase with increase in life expectancy in the future. Developed countries are seriously investing in the related research, and Alzheimerâs disease is one of the most lucrative pharmaceutical markets. For research scientist interest in Alzheimerâs disease goes beyond search for a cure, since this disease is one of the best known examples of numerous degenerative disorders caused by protein aggregation and aging.</p>

<h3 id="state-of-the-art"><a class="toc-backref" href="#id7">State of the art</a><a class="headerlink" href="#state-of-the-art" title="Permalink to this headline">Â¶</a></h3>
<p>Most of the studies of Alzheimerâs disease have explored different evidences that the pathogenesis can be driven by changes in metabolism of Amyloid precursor protein (APP), in particular its membrane-bound C terminal fragment (Î²-CTF-APP), and the related insoluble AÎ² peptides. First, APP protein is cleaved by a membrane-bound protease Î²-secretase to produce Î²-CTF-APP fragment. Second, the Î²-CTF-APP is cleaved by a membrane embedded protease Î³-secretase to produce different amyloid-Î² peptides (AÎ² peptides). Soluble AÎ² 1-40 peptides can be found in healthy brain tissue, while AÎ² 1-42 peptides can be found in protein aggregates in brain tissue of diseased patients. Thus, different therapeutic approaches have targeted Î²-secretase and Î³-secretase in an attempt to increase AÎ² 1-40 production and decrease AÎ² 1-42 production. Impressive efforts in basic and pharmaceutical research have lead to more than a hundred of different therapeutic approaches. Many of them reached clinical trials, including the phase III. Sadly, all of those trials have led to disappointments and in some cases surprisingly daunting results.</p>
<p>The large number of unsettling failures has deeply shaken confidence of pharmaceutical industry in their current drug development strategies. Interestingly, very few people have noticed that thus far the new drug-candidates have been developed with very little knowledge about the underlining molecular mechanism. Precisely, at the time of writing of this proposal a Pubmed search for âAlzheimerâsâ disease gives more than 102234 entries! Only about 61% of all publications on Alzheimerâs disease (60600 entries), can be retrieved using a search that is focused on the âAlzheimerâs AND AÎ² OR amyloidâ. Interestingly, only about 6% of all of the Alzheimerâs disease publications, or about 5876 entries, could be retrieved with a search focused on âAlzheimer AND gamma-secretase OR beta-secretaseâ. These numbers indicate that a wide range of possible pathogenic processes have been explored, and the main problem could be lack of insights at the key molecular events. Without adequate insights in the catalytic mechanism of Î³-secretase, development of the new drug candidates and the early diagnostic methods will remain an expensive guess-work with a high risk of failure.</p>


<h3 id="our-work"><a class="toc-backref" href="#id8">Our work</a><a class="headerlink" href="#our-work" title="Permalink to this headline">Â¶</a></h3>
<p>We are working on those rare and acutely need studies of molecular mechanism using some the best known drug-candidates. Specifically, we analyze the biphasic activation inhibition dose-response curves, one of the best examples of unique molecular mechanism of Î³-secretase. The great majority of drug-candidates that target Î³-secretase show very unusual biphasic activation-inhibition dose response curves at physiological substrate concentration. The biphasic profiles can be observed with cells, experimental animals, and in clinical trials with patients. The biphasic profiles can be observed only at subsaturating physiological substrate concentrations. Thus, they are often unnoticed in industrial high-throughput screening. That is a big oversight, since it is hard to expect that an effective drug-candidate can be developed from a compound that can both activate and inhibit the target enzyme for unknown reasons. The mechanism behind this activation-inhibition phenomenon has to be resolved if we want to continue development of new drug-candidates that target gamma-secretase. Moreover, carefully designed biphasic inhibitors can be used to selectively modulate production of toxic AÎ² 1-42 peptides relative to nontoxic AÎ² 1-40 peptides (i.e. modulators of gamma-secretase activity as opposed to gamma-secretase inhibitors).</p>



<h2 id="the-development-of-mechanism-based-inhibitors-of-human-dna-methyltransferase-dnmt1"><a class="toc-backref" href="#id9">The development of mechanism-based inhibitors of human DNA methyltransferase Dnmt1</a><a class="headerlink" href="#the-development-of-mechanism-based-inhibitors-of-human-dna-methyltransferase-dnmt1" title="Permalink to this headline">Â¶</a></h2>
<div class="figure align-default" id="id5">
<a class="reference internal image-reference" href="../_images/dnmt1-sah.jpg"><img alt="../_images/dnmt1-sah.jpg" src="../_images/dnmt1-sah.jpg" style="width: 720px;"/></a>
<p class="caption"><span class="caption-text">Dnmt1 protein with SAH ligand docked in the active site</span><a class="headerlink" href="#id5" title="Permalink to this image">Â¶</a></p>
</div>
<p>DNA methylation is a part of epigenetic processes that control how our genes respond to our environment. For example, DNA methylation can regulate how learning and training affect our brain and body, as well as many of the autonomous adaptive physiological processes such as skin keratinization or adaptation to different types of nutrition. DNA methylation can also control different pathogenic events, such as psychiatric disorders, allergies, viral infections, and development of cancer.</p>
<p>On technology side, controlled manipulation of DNA methylation in cells can be used for tissue regeneration in clinical laboratories, or in research laboratories for analysis of functional organization of the human genome. For example, DNA methylation regulates transition from embryonic stem cells to differentiated cells. Specific inhibitors of DNA methylation can be used for reversing those processes in engineering of damaged tissues (<a class="reference external" href="https://www.nobelprize.org/prizes/medicine/2012/summary/">The Nobel Prize in Physiology or Medicine 2012</a>).</p>

<h3 id="id1"><a class="toc-backref" href="#id10">State of the art</a><a class="headerlink" href="#id1" title="Permalink to this headline">Â¶</a></h3>
<p>Currently inhibitors of DNA methylation are selling on fine chemicals market for research and clinical laboratories, and on pharmaceutical markets as an FAD approved treatment for myelodysplastic syndrome. There are five major inhibitors on the market. The most popular inhibitor DacogenÂ® has annual market of about 251 million USD. On the fine chemical markets inhibitors of DNA methylation are selling for about 450 USD per 50 mg, what is about 250 times more expensive than gold with the current gold prices. It is important to notice that all of the inhibitors that are currently on the market are very toxic and have limited effectiveness. Thus the corresponding markets are small and unstable.</p>
<p>DNA methylation inhibitors that are currently on the market are based old technology (i.e. 1987) with design limitations that could not be circumvented.</p>


<h3 id="id2"><a class="toc-backref" href="#id11">Our work</a><a class="headerlink" href="#id2" title="Permalink to this headline">Â¶</a></h3>
<p>We are developing mechanism-based warhead inhibitors of mammalian/human DNA methyltransferases with IC50 values below 50 nM. Our inhibitors are based on newest technologies that are result of extensive experimental work in the last 15 years. All our inhibitors have been optimized and pretested using computational simulations and experimental results. Our inhibitors are expected to have much lower toxicity due to specific mechanism of action that has been engineered to the atomic details. Lower toxicity means more applications and bigger markets.</p>
<p>In short term we want to deliver our inhibitors of DNA methylation to research and clinical laboratories. Research laboratories can use the inhibitors for analysis of functional properties of human genome. Studies of functional organization of human genome are the best funded studies in the last 15 years. Clinical laboratories can use the inhibitors for developing processes of tissue engineering and tissue regeneration. Our inhibitors can reach the fine chemical markets very quickly since such markets do not require long testing processes like development of novel drug candidates. The inhibitors that show success on the fine chemical markets can be further developed into novel drug candidates.</p>
<p>The most successful inhibitors can be used for control of functional organization of mammalian genome in research laboratories, biomedical-technology, and ultimately in clinics for treatment of different diseases that depend on epigenetic processes. Some examples are tissue regeneration, oncogenesis, psychiatric and neurological disorders, viral infections, immunological disorders.</p>



<h2 id="supramolecular-organization-of-nad-h-binding-enzymes"><a class="toc-backref" href="#id12">Supramolecular organization of NAD(H)-binding enzymes</a><a class="headerlink" href="#supramolecular-organization-of-nad-h-binding-enzymes" title="Permalink to this headline">Â¶</a></h2>
<p>Description coming soon.</p>

<h3 id="id3"><a class="toc-backref" href="#id13">Our work</a><a class="headerlink" href="#id3" title="Permalink to this headline">Â¶</a></h3>
<p>We have calculated that enzymes that bind NAD(H) can coalesce into a supramolecular complex that controls energy production in cells. Metabolites leaks within the supramolecular complex driven by an electric field indicating that the development of metabolic engineering technologies must involve molecular interactions.</p>



<h2 id="molecular-docking-techniques-using-deep-learning"><a class="toc-backref" href="#id14">Molecular docking techniques using deep learning</a><a class="headerlink" href="#molecular-docking-techniques-using-deep-learning" title="Permalink to this headline">Â¶</a></h2>
<p><a class="reference external" href="https://www.rxdock.org/">RxDock</a> is an open-source high-throughput molecular docking software developed by <a class="reference external" href="https://www.rxtx.tech/">RxTx</a> that aims to be portable and extensible.</p>

<h3 id="id4"><a class="toc-backref" href="#id15">Our work</a><a class="headerlink" href="#id4" title="Permalink to this headline">Â¶</a></h3>
<p>We are researching deep learning approaches to molecular docking with the aim of eventually developing a platform for experimentation with different combinations of deep learning techniques.</p>





          </article>
        </div>
      </div>
    </main>
  </div>
  <footer class="md-footer">
    <div class="md-footer-nav">
      <nav class="md-footer-nav__inner md-grid">
          
            <a href="../research/" title="Research"
               class="md-flex md-footer-nav__link md-footer-nav__link--prev"
               rel="prev">
              <div class="md-flex__cell md-flex__cell--shrink">
                <i class="md-icon md-icon--arrow-back md-footer-nav__button"></i>
              </div>
              <div class="md-flex__cell md-flex__cell--stretch md-footer-nav__title">
                <span class="md-flex__ellipsis">
                  <span
                      class="md-footer-nav__direction"> Previous </span> Research </span>
              </div>
            </a>
          
          
            <a href="../software/" title="Software"
               class="md-flex md-footer-nav__link md-footer-nav__link--next"
               rel="next">
            <div class="md-flex__cell md-flex__cell--stretch md-footer-nav__title"><span
                class="md-flex__ellipsis"> <span
                class="md-footer-nav__direction"> Next </span> Software </span>
            </div>
            <div class="md-flex__cell md-flex__cell--shrink"><i
                class="md-icon md-icon--arrow-forward md-footer-nav__button"></i>
            </div>
          
        </a>
        
      </nav>
    </div>
    <div class="md-footer-meta md-typeset">
      <div class="md-footer-meta__inner md-grid">
        <div class="md-footer-copyright">
          <div class="md-footer-copyright__highlight">
              &#169; Copyright 2015 â 2021, Å½eljko SvedruÅ¾iÄ | Zeljko M. Svedruzic.
              
          </div>
            Created using
            <a href="http://www.sphinx-doc.org/">Sphinx</a> 4.1.2.
             and
            <a href="https://github.com/bashtage/sphinx-material/">Material for
              Sphinx</a>
        </div>
      </div>
    </div>
  </footer>
  <script src="../_static/javascripts/application.js"></script>
  <script>app.initialize({version: "1.0.4", url: {base: ".."}})</script>
  </body>
</html>